Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

965 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP.
Huang X, Meng B, Iqbal J, Ding BB, Perry AM, Cao W, Smith LM, Bi C, Jiang C, Greiner TC, Weisenburger DD, Rimsza L, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Gascoyne RD, Cook JR, Tubbs RR, Jaffe ES, Armitage JO, Vose JM, Staudt LM, McKeithan TW, Chan WC, Ye BH, Fu K. Huang X, et al. Among authors: meng b. J Clin Oncol. 2013 Dec 20;31(36):4520-8. doi: 10.1200/JCO.2012.45.6004. Epub 2013 Nov 12. J Clin Oncol. 2013. PMID: 24220563 Free PMC article.
Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells.
Dong L, Lv H, Li W, Song Z, Li L, Zhou S, Qiu L, Qian Z, Liu X, Feng L, Meng B, Fu K, Wang X, Pan-Hammarström Q, Wang P, Wang X, Zhang H. Dong L, et al. Among authors: meng b. Oncotarget. 2016 May 31;7(22):33350-62. doi: 10.18632/oncotarget.9061. Oncotarget. 2016. PMID: 27147575 Free PMC article.
Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: correlations with clinicopathological characteristics and clinical outcome.
Wang X, Zhang T, Song Z, Li L, Zhang X, Liu J, Liu X, Qiu L, Qian Z, Zhou S, Feng L, Hu G, Meng B, Zhai Q, Ren X, Fu K, Li L, Wang P, Zhang H. Wang X, et al. Among authors: meng b. Int J Cancer. 2019 Sep 1;145(5):1414-1422. doi: 10.1002/ijc.32144. Epub 2019 Feb 4. Int J Cancer. 2019. PMID: 30664812
Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCL.
Li L, Zhang X, Zhang T, Song Z, Hu G, Li W, Li L, Qiu L, Qian Z, Zhou S, Liu X, Feng L, Pan Y, Zhai Q, Meng B, Ren X, Fu K, Wang P, Wang X, Zhang H. Li L, et al. Among authors: meng b. Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):e381-e389. doi: 10.1016/j.clml.2018.06.010. Epub 2018 Jun 19. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29983382
965 results